Literature DB >> 24203505

Mild cognitive impairment: risk of dementia according to subtypes.

Cecilia M Serrano1, Carol Dillon, Adriana Leis, Fernando E Taragano, Ricardo Francisco Allegri.   

Abstract

UNLABELLED: Mild cognitive impairment (MCI) has 3 clinical subtypes: amnestic (aMCI), multiple domains (mdMCI) and non-amnestic single domain (na-SD-MCI) whose evolutive possibility to dementia has not been profoundly studied.
OBJECTIVE: This paper aims to determine the conversion to dementia of the different subtypes of MCI and determine risk factors associated to conversion to dementia.
METHODS: A total of 127 patients diagnosed with MCI (age=70.21; SD=13.17) were evaluated with a neuropsychological and neuropsychiatric battery. They were classified into 3 groups: amnestic MCI (n=20), multiple-domain MCI (n=98), non-amnestic MCI (n=9). Seventeen normal subjects (age=74.59; SD=10.63) were included.
RESULTS: Of those included, 27.1% developed Alzheimer's type dementia [average time for conversion to Alzheimer's dementia (AD) 11.12 months (SD=0.183)]. None of the controls developed dementia. Thirty-five percent (n=7) of amnestic MCI converted to AD: 20% (n=4) at 6 months and 15% (n=3) at 12 months); 11.1% (n=1) of the non-amnestic single domain MCI converted to AD at 6 months. It was found that 31.6% (n=31) of multiple domain MCI rotated to AD: 15.3% (n=15) at 6 months and 16.3% (n=16) at 12 months. Age (p<0.05, β=1.03) increased the likelihood of rotation to AD. Multi-domain MCI subtype was the most frequent. However, the conversion to dementia in amnestic subtype was the highest, age and retirement being the variables that increased the likelihood of conversion to Dementia.

Entities:  

Mesh:

Year:  2013        PMID: 24203505

Source DB:  PubMed          Journal:  Actas Esp Psiquiatr        ISSN: 1139-9287            Impact factor:   1.196


  4 in total

1.  Predicting conversion to dementia in a memory clinic: A standard clinical approach compared with an empirically defined clustering method (latent profile analysis) for mild cognitive impairment subtyping.

Authors:  Bernadette McGuinness; Suzanne L Barrett; John McIlvenna; Anthony Peter Passmore; Gillian W Shorter
Journal:  Alzheimers Dement (Amst)       Date:  2015-11-02

2.  Study of brain morphology change in Alzheimer's disease and amnestic mild cognitive impairment compared with normal controls.

Authors:  Huanqing Yang; Hua Xu; Qingfeng Li; Yan Jin; Weixiong Jiang; Jinghua Wang; Yina Wu; Wei Li; Cece Yang; Xia Li; Shifu Xiao; Feng Shi; Tao Wang
Journal:  Gen Psychiatr       Date:  2019-04-16

3.  Molecular Changes in Circulating microRNAs' Expression and Oxidative Stress in Adults with Mild Cognitive Impairment: A Biochemical and Molecular Study.

Authors:  Hadeel A Al-Rawaf; Ahmad H Alghadir; Sami A Gabr
Journal:  Clin Interv Aging       Date:  2021-01-08       Impact factor: 4.458

Review 4.  Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies.

Authors:  Anders Wallin; Arto Nordlund; Michael Jonsson; Kaj Blennow; Henrik Zetterberg; Annika Öhrfelt; Jacob Stålhammar; Marie Eckerström; Mårten Carlsson; Erik Olsson; Mattias Göthlin; Johan Svensson; Sindre Rolstad; Carl Eckerström; Maria Bjerke
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.